GlobeNewswire

BNP Paribas Announces Senior Staff Appointments in the USA and the Americas

Dela

NEW YORK, June 14, 2018 (GLOBE NEWSWIRE) -- As BNP Paribas continues to evolve its platform in the region and build on the significant growth to date, as well as reinforce its commitment to clients, it is pleased to announce the appointments of several executive members:

Jean-Yves Fillion: CEO of BNP Paribas USA and CEO of CIB Americas becomes Chairman of CIB Americas and continues to serve as CEO of BNP Paribas USA, BNP Paribas' intermediate holding company that oversees the bank's wholesale and retail activities including Bank of the West and First Hawaiian. In these two roles, Mr. Fillion is responsible for the bank's regional corporate strategy and will sponsor the bank's relationships with the region's most important clients and external stakeholders. Mr. Fillion has been with BNP Paribas for 33 years, 26 of which he has spent in the United States between Chicago, Los Angeles and New York.

Bob Hawley: Deputy CEO CIB Americas becomes CEO of CIB Americas. Reporting to Jean-Yves Fillion regionally and to Yann Gérardin, Head of Corporate and Institutional Banking, globally, Mr. Hawley will continue to serve as Head of the Institutional Platform Americas (which includes Global Markets, Securities Services, and Financial Institutions Client Coverage) and Head of Global Markets Americas. Mr. Hawley will also be responsible for the Brazilian CIB platform. He has been with BNP Paribas since 1997 in increasing roles within CIB in Tokyo, Hong Kong, London and New York.

Pierre Veyres: is appointed Deputy Head of CIB Americas and Head of the Corporate Platform Americas, (which includes Corporate Coverage, Financing Solutions, Credit and Portfolio Management, and Advisory). Reporting to Bob Hawley, Mr. Veyres will be responsible for leading the Group's strategy to grow the corporate franchise and will be a member of the CIB Americas Executive Committee. He will oversee the CIB platforms in Hispanic LATAM and Canada. Mr. Veyres joins the Americas team from APAC, where he has served as the CEO of the BNP Paribas Singapore branch as well as the Head of Territory for Singapore and Head of CIB Southeast Asia since October 2013.

Philippe Ricard: appointed COO CIB Americas. Mr. Ricard, who's been in the region since 2017, is replacing Bruno d'Illiers, who is moving to a new role with the Bank in Paris. In his capacity as COO, CIB Americas, Mr. Ricard will report to Bob Hawley. Mr. Ricard will continue to serve as COO of BNP Paribas USA for which he reports to Mr. Fillion. Since joining the Group in 1989, Mr. Ricard has held a wide range of leadership positions across BNP Paribas' key regions and businesses, most recently as Global Head of Asset and Fund Services within BNP Paribas Securities Services.

Sonja Volpe: Country Head of Canada. Ms. Volpe brings over 17 years of experience covering Canadian financial institutions and public sector clients. She first joined BNP Paribas in 2015 as Head of Financial Institutions Coverage in Canada and has been instrumental in developing the bank's institutional client franchise in the region. She will continue to drive the bank's business growth as well as further develop Canada as an operational platform in the region. With over 800 employees in offices in Montreal and Toronto, Canada plays an important role in the Americas.

Thalès Gabay: appointed Head of ALM Treasury CIB Americas. Mr. Gabay is replacing Jonathan Light who is retiring. Mr. Gabay most recently served as Head of ALMT for APAC, following a successful tenure as Head of ALMT for the Latin America region.

Amanda Rajkumar: appointed Head of Human Resources for BNP Paribas USA and CIB Americas. Ms. Rajkumar brings with her over 25 years' experience in Human Resources within the investment banking arena. She joined BNP Paribas in May 2009 as Head of HR for BNP Paribas Securities Services in the UK, and most recently, she was responsible for Global Markets and Financial Institutions Coverage Human Resources in London and previous to that headed Global Fixed Income Human Resources for 5 years.

Emmanuelle Bury: appointed Chief Conduct and Control Officer (CCCO) for BNP Paribas USA and CIB Americas. Ms. Bury comes from BNP Paribas Paris where she was the Global COO for the ALM Treasury Group. She will be joining the CIB Americas Executive Committee and will ensure that all Conduct & Control matters are well incorporated into the governance and working principles of all business lines.

All appointments are effective in June except: Sonja Volpe, effective July 1; Philippe Ricard, effective August 1; and Pierre Veyres, effective September 1.

Yann Gérardin, Head of Corporate and Institutional Banking, said: "BNP Paribas has experienced solid growth over the past few years, and now, backed by the Bank's commitment to invest substantial capital and resources in our Americas platform we are poised to elevate our business to the next level. A key factor in our success remains our continued focus on our clients: supporting their needs globally and providing them with strategic guidance. To support this mission we are investing in our leadership, which includes these appointments."

Jean-Yves Fillion, CEO of BNP Paribas USA & Chairman of CIB Americas, said of the appointments: "BNP Paribas is at a pivotal moment for the Americas platform. As the competitive landscape evolves, our business is well-positioned to continue our strong progress toward becoming one of the top European banks in the region. We have a tremendous opportunity in front of us in both our wholesale and retail businesses as a unified region with a global offering that differentiates the bank in the marketplace. I am excited for what the bank will achieve in the years ahead."

PRESS CONTACTS
Ilias Catsaros
+1 917 254 6365
ilias.catsaros@us.bnpparibas.com

Mylene Benmoussa
+1 646 322 5221
mylene.benmoussa@us.bnpparibas.com

About BNP Paribas in the USA
BNP Paribas has built a strong and diversified presence in the United States to support its client base. The bank employs over 16,000 people and has had a presence in the USA since the late 1800s. Bank of the West and First Hawaiian Bank (together BancWest, part of Retail Banking & Services) serve nearly 2.5 million individuals and businesses through a network of more than 650 branches and business centers. Large corporate and institutional clients are serviced by BNP Paribas' Corporate & Institutional Banking franchise that has a presence in the main US cities, in addition to a global reach through a network of offices in EMEA and APAC. The bank also offers asset management services through BNP Paribas Asset Management (part of Retail Banking & Services) as well as Real Estate and Fleet Services through partnerships. www.usa.bnpparibas.

About BNP Paribas 
BNP Paribas is a leading bank in Europe with an international reach. It has a presence in 73 countries, with more than 196,000 employees, including more than 149,000 in Europe. The Group has key positions in its three main activities: Domestic Markets and International Financial Services (whose retail banking networks and financial services are covered by Retail Banking & Services) and Corporate & Institutional Banking, which serves two client franchises: corporate clients and institutional investors. The Group helps all its clients (individuals, community associations, entrepreneurs, SMEs, corporate and institutional clients) to realize their projects through solutions spanning financing, investment, savings and protection insurance. In Europe, the Group has four domestic markets (Belgium, France, Italy and Luxembourg) and BNP Paribas Personal Finance is the European leader in consumer lending. BNP Paribas is rolling out its integrated retail banking model in Mediterranean countries, in Turkey, in Eastern Europe and a large network in the western part of the United States. In its Corporate & Institutional Banking and International Financial Services activities, BNP Paribas also enjoys top positions in Europe, a strong presence in the Americas as well as a solid and fast-growing business in Asia-Pacific.                           




This announcement is distributed by Nasdaq Corporate Solutions on behalf of Nasdaq Corporate Solutions clients.
The issuer of this announcement warrants that they are solely responsible for the content, accuracy and originality of the information contained therein.
Source: BNP Paribas Securities Corp. via Globenewswire

Om

GlobeNewswire



Följ GlobeNewswire

Abonnera på våra pressmeddelanden. Endast mejladress behövs och den används bara här. Du kan avanmäla dig när som helst.

Senaste pressmeddelandena från GlobeNewswire

Karolinska Development delays publication of its Annual Report for 2018 and changes date for the Annual General Meeting26.4.2019 08:00:00 CESTPressmeddelande

STOCKHOLM, SWEDEN - 26 April 2019. Karolinska Development AB (Nasdaq Stockholm: KDEV) announces today that The Board of Directors has decided to delay the publication of its Annual Report for 2018. Karolinska Development has changed the date for the Annual General Meeting to June 26, 2019. The date for publication of the Annual Report for 2018 has been changed from April 26 to April 30, 2019. Karolinska Development has changed the date for the Annual General Meeting from June 4 to June 26, 2019. Notice to the Annual General Meeting will be published in a separate press release. For more information, please contact: Viktor Drvota, CEO, Karolinska Development AB Phone: +46 73 982 52 02, e-mail: viktor.drvota@karolinskadevelopment.com Fredrik Järrsten, CFO, Karolinska Development AB Phone: +46 70 496 46 28, e-mail: fredrik.jarrsten@karolinskadevelopment.com TO THE EDITORS About Karolinska Development AB Karolinska Development AB (Nasdaq Stockholm: KDEV) is a Nordic life sciences investmen

Karolinska Development senarelägger publicering av årsredovisningen för 2018 och meddelar nytt datum för årsstämma26.4.2019 08:00:00 CESTPressmeddelande

STOCKHOLM, SVERIGE - 26 april 2019. Karolinska Development AB (Nasdaq Stockholm: KDEV) meddelar idag att styrelsen har beslutat att senarelägga publiceringen av årsredovisningen för 2018. Karolinska Development har ändrat datum för årsstämman till den 26 juni 2019. Publiceringen av årsredovisningen för 2018 flyttas från den 26 april till den 30 april 2019. Karolinska Development har ändrat datum för årsstämman från den 4 juni till den 26 juni 2019. Kallelse till årsstämman kommer att publiceras senare i ett separat pressmeddelande. För ytterligare information, vänligen kontakta: Viktor Drvota, vd, Karolinska Development AB Tel: +46 73 982 52 02, e-mail: viktor.drvota@karolinskadevelopment.com Fredrik Järrsten, finanschef, Karolinska Development AB Tel: +46 70 496 46 28, e-mail: fredrik.jarrsten@karolinskadevelopment.com TILL REDAKTÖRERNA Om Karolinska Development AB Karolinska Development AB (Nasdaq Stockholm: KDEV) är ett nordiskt investmentbolag inom life science. Bolaget fokuserar p

Karolinska Developments portföljbolag Aprea Therapeutics har fått särläkemedelsstatus och snabbspårstatus från FDA för APR-24616.4.2019 12:46:00 CESTPressmeddelande

STOCKHOLM, SVERIGE - 16 april 2019. Karolinska Development AB meddelar idag att portföljbolaget Aprea Therapeutics har av FDA fått särläkemedelsstatus för APR-246 för behandling av patienter med TP53-muterad myelodysplastiskt syndrom (MDS). Dessutom ger FDA bolaget snabbspårstatus (Fast Track Designation), för APR-246 för behandling av MDS. Amerikanska läkemedelsverket, FDA, ger särläkemedelsstatus till läkemedelskandidater för att snabba på utvärderingen och utvecklingen av säkra och effektiva behandlingar av ovanliga sjukdomar. Särläkemedelsstatus ger företag både regulatoriska och kommersiella incitament genom att läkemedlet får marknadsexklusivitet på den amerikanska marknaden i sju år efter marknadsgodkännande samtidigt som företaget får stöd från FDA när det gäller designen av kliniska prövningar, skatteförmåner för kostnader kopplade till kliniska prövningar och avgiftsbefrielse från FDA. FDA:s snabbspår underlättar utvecklingen av läkemedel som är avsedda för att behandla allva

Karolinska Development's portfolio company Aprea Therapeutics has received FDA Orphan Drug Designation and Fast Track Designation for APR-24616.4.2019 12:46:00 CESTPressmeddelande

STOCKHOLM, April 16, 2019. Karolinska Development's portfolio company Aprea Therapeutics has from FDA received an Orphan Drug Designation for APR-246 for the treatment of patients with Myelodysplastic Syndromes (MDS) having a TP53 mutation. In addition, FDA has also granted Fast Track Designation to APR-246 for treatment of MDS. Orphan Drug Designation is granted by the FDA Office of Orphan Products Development to advance the evaluation and development of safe and effective therapies for the treatment of rare diseases. The designation can provide development and commercial incentives for designated compounds and medicines, including eligibility for a seven-year period of market exclusivity in the U.S. after product approval, FDA assistance in clinical trial design, tax credits related to clinical trial expenses, and an exemption from FDA user fees. The FDA's Fast Track program facilitates the development of drugs intended to treat serious conditions and that have the potential to addre

Bergman & Beving AB: Bergman & Beving förvärvar KGC10.4.2019 14:00:00 CESTPressmeddelande

Pressmeddelande Bergman & Beving förvärvar KGC Bergman & Beving har idag tecknat avtal om förvärv av samtliga aktier i KGC Verktyg & Maskiner AB. KGC, med säte i Älvsjö, har i mer än 60 år utvecklat och levererat kvalitetsverktyg och tillbehör för murning och plattsättning i det egna varumärket KGC. Bolaget omsätter cirka 80 MSEK per år, och har 24 anställda. "KGC är ett ledande varumärke med högt anseende hos murare och plattsättare och har en mycket stark ställning på den svenska marknaden", säger Pontus Boman, VD och koncernchef. Tillträde beräknas ske den 1 maj 2019 och förvärvet bedöms ha en marginellt positiv påverkan på Bergman & Bevings resultat per aktie under innevarande räkenskapsår. Stockholm den 10 april 2019 Bergman & Beving AB (publ) För ytterligare information kontakta: Pontus Boman, VD & Koncernchef, telefon 010-454 77 00 Peter Schön, CFO, telefon 070-339 89 99 Denna information lämnades, genom ovanstående kontaktpersoners försorg, för offentliggörande den 10 april 201

Bergman & Beving AB: Bergman & Beving acquires KGC10.4.2019 14:00:00 CESTPressmeddelande

Press release Bergman & Beving acquires KGC Bergman & Beving has today signed an agreement to acquire all shares in KGC Verktyg & Maskiner AB. KGC, based in Älvsjö, has for more than 60 years developed and delivered quality tools and accessories for bricklayers and tilers in its own brand KGC. The business has a turnover of approximately SEK 80 million per year, and has 24 employees. "KGC is a leading brand with high reputation among bricklayers and tilers and has a very strong position in the Swedish market," says Pontus Boman, President and CEO. The closing is taking effect on 1 May 2019 and the acquisition is expected to have a marginal positive impact on Bergman & Beving's earnings per share during the current fiscal year. Stockholm, 10 April 2019 Bergman & Beving AB (publ) For further information, please contact: Pontus Boman, President & CEO, Tel: +46 10 454 77 00 Peter Schön, CFO, Tel: +46 70 339 89 99 The information was submitted for publication, through the agency of the cont

I vårt pressrum kan du läsa de senaste pressmeddelandena, få tillgång till pressmaterial och hitta kontaktinformation.

Besök vårt pressrum